50th ASH Annual Meeting and Exposition (December 6 - 9, 2008): Acute Lymphoblastic Leukemia

Before you can access ASH's online program, you must agree to the following:

Abstracts submitted to the ASH Annual Meeting are considered embargoed from the time of submission.
For the research and study to be eligible for presentation at the ASH annual meeting, information contained in the abstract, as well as additional data and information to be presented about the research and/or study at the annual meeting, may not be made public before the abstract has been published/presented at the ASH annual meeting.

Last updated January 16, 2009. Please note that this site represents the latest program changes
and differs from the print version in some details.

Acute Lymphoblastic Leukemia

Saturday, December 6, 2008: 4:00 PM-5:30 PM

2001-2003-2005 - West (Moscone Center)

Sunday, December 7, 2008: 9:30 AM-11:00 AM

2001-2003-2005 - West (Moscone Center)

Molecular Determinants of Treatment Response in Acute Lymphoblastic Leukemia

Dario Campana, MD, PhD

Oncology and Pathology, St. Jude Children's Research Hospital, Memphis, TN

Treatment of Acute Lymphoblastic Leukemia in Children and Adolescents: Peaks and Pitfalls

Nita L. Seibel, MD

Cancer Therapy Evaluation Program, National Cancer Institute, National Institutes of Health, Bethesda, MD

Acute Lymphoblastic Leukemia in Adults: Is There Progress?

Adele K. Fielding, PhD

Royal Free and University College Medical School, London, United Kingdom

See more of: Education Program

<< Previous Session | Next Session >>